New Blood-Filtering strategy aims to save lives from weed killer poisoning
NCT ID NCT07234383
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether starting a specific type of blood filtering (hemodiafiltration) immediately after a standard blood-cleaning treatment (hemoperfusion) can improve survival in people with severe diquat poisoning. Diquat is a herbicide that can cause rapid kidney failure and death. The study will enroll 24 adults with high levels of diquat in their blood. Researchers will track how many survive and how long they live, aiming to see if this faster approach is safe and promising enough for larger studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Continuous veno-venous hemodiafiltration (a type of blood filtering procedure)
- What this could lead to
- If successful, this could establish a faster, more effective way to filter the blood after diquat poisoning, potentially reducing deaths.
- What could go wrong
- This is a very early, small (24 people) single-arm trial with no comparison group. The approach may not improve outcomes and carries risks from the procedure itself, like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIQUAT POISONING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.